Pediatric end-stage liver disease
Pediatric end-stage liver disease (also known as PELD) is a severe liver disease that occurs in children. It is the final stage of chronic liver disease where the liver has lost all its functions. The only definitive treatment for PELD is liver transplantation.
Causes[edit]
PELD can be caused by a variety of conditions, including biliary atresia, metabolic disorders, autoimmune diseases, and viral infections. In some cases, the cause of PELD is unknown.
Symptoms[edit]
The symptoms of PELD can vary widely and may include jaundice, ascites, variceal bleeding, and hepatic encephalopathy. Children with PELD may also experience growth failure and developmental delays.
Diagnosis[edit]
The diagnosis of PELD is based on a combination of clinical symptoms, laboratory tests, and imaging studies. The Model for End-Stage Liver Disease (MELD) score is often used to assess the severity of liver disease and prioritize patients for liver transplantation.
Treatment[edit]
The primary treatment for PELD is liver transplantation. Other treatments may include medications to manage symptoms and complications, nutritional support, and in some cases, surgical procedures to manage complications of liver disease.
Prognosis[edit]
The prognosis for children with PELD depends on a variety of factors, including the underlying cause of the disease, the child's overall health, and the availability of a suitable liver donor.
See also[edit]
- Liver disease
- Liver transplantation
- Chronic liver disease
- Biliary atresia
- Metabolic disorders
- Autoimmune diseases
- Viral infections
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
